Syra Health receives Nasdaq delisting notice for bid price below $1.00 for 30 consecutive days

Syra Health Corp

Nasdaq notified Syra Health on Oct 18, 2024 that its common stock bid price closed below $1.00 for 30 business days, violating Listing Rule 5550(a)(2).
Company has 180 calendar days, until April 16, 2025, to regain compliance by achieving $1.00 closing bid for at least 10 consecutive business days.
If non-compliance continues, Syra may seek a second 180-day period or appeal a delisting determination to a Nasdaq hearings panel.
Common stock (SYRA) continues trading on Nasdaq during the cure period; company may consider options such as a reverse stock split.
No assurance the company will maintain its Nasdaq listing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.